TCT Meeting Highlights Results for Bioresorbable Scaffold and Metallic EES Comparable in ABSORB II and III Trials By Brian Ellis Publish Date October 12, 2015 Similar outcomes were reported for an everolimus-eluting bioresorable vascular scaffold and a metallic everolimus-eluting stent in both ABSORB II and III trials.
Valve-in-Valve Registry Data Demonstrate Positive 1-Year Results for Transcatheter Aortic Valve Replacement
